Therapy by rFVIIa (Novoseven) in patients with haemophilia A and inhibitor: factors influencing total, therapy effectiveness

被引:0
|
作者
Hulikova, M. [1 ]
Hulikova, J. [1 ]
Brabec, P. [2 ]
机构
[1] Ctr Haemostasis & Thrombosis, Kosice, Slovakia
[2] Masaryk Univ, Inst Biostat & Anal, Brno, Czech Republic
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:37 / 37
页数:1
相关论文
共 50 条
  • [1] Optimizing thrombelastography (TEG) assay conditions to monitor rFVIIa (NovoSeven®) therapy in haemophilia a patients
    Viuff, Dorthe
    Andersen, Soren
    Sorensen, Brit B.
    Lethagen, Stefan
    THROMBOSIS RESEARCH, 2010, 126 (02) : 144 - 149
  • [2] Surgical Experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX
    Valentino, L. A.
    Cooper, D. L.
    Goldstein, B.
    HAEMOPHILIA, 2011, 17 (04) : 579 - 589
  • [3] Sequential therapy with APCC and rFVIIa in two haemophilia inhibitor patients undergoing four dental extraction procedures
    Stefanska-Windyga, E.
    Czubak, G.
    Baran, B.
    Windyga, J.
    HAEMOPHILIA, 2010, 16 : 78 - 79
  • [4] FACTORS INFLUENCING THE EFFECTIVENESS OF ANTIPLATELET THERAPY
    Kantemirova, Bela
    Zhidovinov, Aleksei
    Abdullaev, Musalitdin
    Orlova, Ekaterina
    Chernysheva, Elena
    Sultanova, Oksana
    ARCHIV EUROMEDICA, 2022, 12 (01): : 19 - 25
  • [5] Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery
    Shapiro, AD
    Gilchrist, GS
    Hoots, WK
    Cooper, HA
    Gastineau, DA
    THROMBOSIS AND HAEMOSTASIS, 1998, 80 (05) : 773 - 778
  • [7] Thrombelastography rotational (ROTEM®) utility for monitoring patients with haemophilia and factor VIII inhibitors treated with rFVIIa (NOVOSEVEN®)
    Garcia-Rodriguez, M.
    Alvarez, M.
    Martin-Salces, M.
    Fernandez, I
    Butta, N.
    Rivas, I
    Munoz, I
    Jimenez-Yuste, V
    Hernandez-Navarro, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1135 - 1135
  • [8] Potential impact of the availability of a larger NovoSeven® (RFVIIA) vial size in the treatment of acute bleed episodes in patients with haemophilia
    de Miranda, P. A. P.
    Starzyk, K.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 472 - 472
  • [9] Rapid rFVIIa enhanced on-demand dosing in haemophilia inhibitor patients
    Morfini, Massimo
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (02) : 111 - 118
  • [10] Genetic factors influencing inhibitor development in a cohort of South African haemophilia A patients
    Lochan, A.
    Macaulay, S.
    Chen, W. C.
    Mahlangu, J. N.
    Krause, A.
    HAEMOPHILIA, 2014, 20 (05) : 687 - 692